Skin News and Research

RSS

3dgenome program should lead to a breakthrough in our understanding of how our genome functions

Under the EU Sixth Framework Programme (FP6) for Research and Development (2002-2006) 2.2 million Euros have been awarded to the 3DGENOME-research program.

17 Jun 2004

Emergence of MRSA bacteria that are increasingly resistant to vancomycin

Researchers had previously thought that such bacteria were emerging from only one sort of the MRSA superbug, but the new study has shown that they have evolved in all major types.

17 Jun 2004

No beneficial medical effects from liposuction

Liposuction is no substitute for dieting when it comes to preventing diabetes, hypertension and heart disease, according to researchers at Washington University School of Medicine in St. Louis.

16 Jun 2004

Results from study of Rituxan in rheumatoid arthritis show promise

Genentech, Inc., Biogen Idec and Roche have announced that the New England Journal of Medicine published the results of a Phase IIa study showing that two doses of Rituxan® (Rituximab), administered two weeks apart, improved symptoms in patients with moderate-to-severe rheumatoid arthritis (RA) for up to 48 weeks when combined with methotrexate (MTX), compared to MTX alone.

16 Jun 2004

Pulsed dye laser therapy not effective in treating acne

Unfortunately, there also appears to be no benefit, at least with one type of laser treatment called pulsed dye laser therapy, according to new research from the University of Michigan Health System.

16 Jun 2004

New embryonic stem cells technology

An MIT team has developed new technology that could jump-start scientists' ability to create specific cell types from human embryonic stem cells, a feat with implications for developing replacement organs and a variety of other tissue engineering applications.

14 Jun 2004

Textured titanium medical implants may be better than smooth ones

Medical implants – from catheters that deliver long-term life support to joint replacements – may work better when their surfaces are on the rough side, new research suggests.

14 Jun 2004

For nearly 50% of women, hair loss was the most distressing side effect of chemotherapy

Information and support charity CancerBACUP has dramatically revised its booklet on hair loss - the most traumatic side effect of cancer treatment for many women. The revamped booklet also now includes practical advice for patients from minority ethnic groups.

14 Jun 2004

West Nile virus prevention

Whether you're hitting the hiking trail, barbecuing in the back yard, or camping out in the great outdoors, you'll want to protect against mosquito bites.

14 Jun 2004

Synthetic skin from human embryonic stem cells

A Massachusetts Institute of Technology team has developed new technology that could jump-start scientists' ability to create specific cell types from human embryonic stem cells, a feat with implications for developing replacement organs and a variety of other tissue engineering applications.

14 Jun 2004

Arizona advisory on tick removal

As hotter temperatures draw Arizonans to the state’s high country, Department of Health Services Director Catherine Eden advised residents to take precautions against tick bites because some ticks carry germs that cause disease, including Rocky Mountain spotted fever.

11 Jun 2004

U.S. team to battle malaria in Peru

In the middle of the Peruvian Amazon, a battle against malaria – the second largest killer of people worldwide – will be undertaken by an international team of researchers led by tropical disease specialist Joseph Vinetz, M.D., from the University of California, San Diego (UCSD) School of Medicine.

11 Jun 2004

Common weeds may be better than herbal cousins for preventing and curing a host of diseases

Unwanted, pulled or poisoned, the lowly weed is sometimes better than its highly touted “herbal” cousins for preventing and curing a host of diseases, according to University of Florida research.

10 Jun 2004

Remicade shows improvement in both the arthritis and psoriasis associated with psoriatic arthritis

In this trial, REMICADE provided a 70 percent improvement (as measured by ACR 70) in symptoms of arthritis in nearly one-third of patients, compared with only 2 percent of patients on placebo at 24 weeks.

10 Jun 2004

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that’s FDA-approved to treat vascular disease, according to a University of Rochester study published in this month’s Journal of Clinical Oncology.

10 Jun 2004